13G Filing: RA Capital Management and Derma Sciences, Inc. (DSCI)

In a new filing with the Securities and Exchange Commission, Peter Kolchinsky‘s RA Capital Management disclosed a position in Derma Sciences Inc (NASDAQ:DSCI). According to the filing, RA Capital owns a passive stake in the company, which contains 2.06 million shares, equal to 8% of Derma Sciences’ outstanding stock.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
RA Capital Management, LLC 0 2,055,676 0 2,055,676 2,055,676 8.0%
Peter Kolchinsky 0 2,055,676 0 2,055,676 2,055,676 8.0%
RA Capital Healthcare Fund, L.P. 0 1,613,065 0 1,613,065 1,613,065 6.3%
Peter Kolchinsky
Peter Kolchinsky
RA Capital Management

Page 1 of 8 SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of
1934

(Amendment No.__)*

Derma Sciences, Inc.

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

249827502

(CUSIP Number)

January 20, 2016

(Date of Event Which Requires Filing of
this Statement)

Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:

[   ] Rule 13d-1(b)

[X] Rule 13d-1(c)

[   ] Rule 13d-1(d)

*The remainder of this cover page shall
be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, see the Notes).

Follow Derma Sciences Inc. (NASDAQ:DSCI)